Cellular response to tissue hypoxia and its involvement in disease progression.
about
Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid ArthritisPHD2: from hypoxia regulation to disease progressionEfficacy of pEgr-1-endostatin combined with ionizing radiation on hypoxic conditions in nude mice bearing SKOV3 ovarian carcinoma.Estrogen suppresses cardiac IL-6 after trauma-hemorrhage via a hypoxia-inducible factor 1 alpha-mediated pathway.Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophagesEGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda.HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis.Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in GlioblastomaDefect of adaptation to hypoxia in patients with COPD due to reduction of histone deacetylase 7Normalizing dysfunctional purine metabolism accelerates diabetic wound healingReactive oxygen species and erectile dysfunction: possible role of NADPH oxidase.Erythropoietin: elucidating new cellular targets that broaden therapeutic strategiesHypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.Erythropoietin and oxidative stress.Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases.Targeting tumour necrosis factor-α in hypoxia and synaptic signalling.Nanoscale Metal-Organic Frameworks for Ratiometric Oxygen Sensing in Live CellsBerberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer.Myringotomy in the Junbo mouse model of chronic otitis media alleviates inflammation and cellular hypoxia.Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.Ratiometric single-nanoparticle oxygen sensors for biological imagingAn up-to-date anti-cancer treatment strategy focusing on HIF-1alpha suppression: its application for refractory ovarian cancer.Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells.Paeonol enhances the sensitivity of human ovarian cancer cells to radiotherapy-induced apoptosis due to downregulation of the phosphatidylinositol-3-kinase/Akt/phosphatase and tensin homolog pathway and inhibition of vascular endothelial growth factThe influence of low oxygen on macrophage response to Leishmania infection.Expression of heme oxygenase-1, hypoxia inducible factor-1alpha, and ubiquitin in peripheral inflammatory cells from patients with coronary heart disease.Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions.Development of polymeric nanoprobes with improved lifetime dynamic range and stability for intracellular oxygen sensing.A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats.Erythropoietin-stimulated endothelial cells support erythroid cell differentiation of CD34(+) haematopoietic progenitors.Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
P2860
Q26738338-C970B210-0766-499B-95E1-EFB6F8B4C70FQ28069316-0E503F5B-5255-49A3-96CF-A85048A040FAQ33598166-DB6FBDAF-9FFB-4325-824B-877B66DDA7B0Q33621727-286186B7-6BD1-4935-BDBD-36D1F2EB2A00Q34003967-A3EE4CEC-5F8D-4B34-AD2C-EEDBB8DC5ACFQ34279167-9D21739C-D81E-4D63-BC71-6F0BCE6FF90BQ34845463-2E1A7EF0-3E03-4D7A-9136-46D2FDB1E8BEQ35126769-19B067FC-D3FF-4793-80CC-3613E1FD8297Q35225120-4A2DFE43-3BEB-4BD7-9EA9-1E6CB8E7D182Q35901357-B1B0B4CF-12E9-4844-A3E6-70FBB8E60DC4Q35929930-E5CCCABE-AE8C-4AFF-BFB2-60DA7B968561Q36262699-FD5ED642-2851-4303-8D97-C45263F42449Q36629849-B099CD14-CF0E-4D8F-B6AA-04FF0F1B1889Q36740470-6E96EEA6-1B44-41AF-A2F6-695A9C02429DQ36753387-7DFCA5C1-A228-441E-B068-38D7208BE9D3Q36944477-48551947-46DB-437C-9AA4-CE23195E9131Q37416379-162F7605-6AB7-4C11-905C-567F88A83202Q38077697-C7B0FFF0-2EAE-4A5A-8EBE-2D781F73CDE7Q38795184-64C16D23-AC41-4EA0-934E-E8F9836443DAQ38989346-A309D06C-5CDA-4C6C-B5D7-8774A153D296Q39214894-27C7579A-635C-4538-9420-8D4AE33557F5Q39299094-2564AEA0-90FD-41FC-B2BF-C1E3328B0D1BQ39878136-2C2DFAB5-56CB-4A04-8A65-E8C800B7EEA4Q40020045-B128679E-EF32-479E-833D-D22C9704ABD6Q40153022-9193D323-EB64-4A77-B1BF-2D6D69E1C0FFQ41623770-43276BAF-727A-4CF9-AA00-129C5E772CB6Q44526578-4B6360DC-B4CF-429A-9C2E-0A013793C2BCQ44833533-B17BC9F2-5F9C-4801-A18A-D6C33B29E6EBQ46521228-5F2463EB-2D3F-47FD-ABDE-0C3620E009CCQ46779161-A09782A1-BFDC-4F69-8D31-6D868A3812D4Q48161042-110BB6D9-8EBA-47DF-91DA-DF0B8C2D1C78Q50902122-FA00B201-48E7-4BCF-AEAB-97DBFF259C2FQ54373864-3F58A580-6414-47D7-B5D0-F276AEE6915D
P2860
Cellular response to tissue hypoxia and its involvement in disease progression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cellular response to tissue hypoxia and its involvement in disease progression.
@ast
Cellular response to tissue hypoxia and its involvement in disease progression.
@en
type
label
Cellular response to tissue hypoxia and its involvement in disease progression.
@ast
Cellular response to tissue hypoxia and its involvement in disease progression.
@en
prefLabel
Cellular response to tissue hypoxia and its involvement in disease progression.
@ast
Cellular response to tissue hypoxia and its involvement in disease progression.
@en
P2860
P1476
Cellular response to tissue hypoxia and its involvement in disease progression.
@en
P2093
Eiji Ikeda
P2860
P304
P356
10.1111/J.1440-1827.2005.01877.X
P577
2005-10-01T00:00:00Z